1. Steward, W.P., Scarffe, J.H., Austin, R., Bonnem, E., Thatcher, N., Morgenstern, G., and Crowther, D., Br. J. Cancer, 1989, vol. 59, no. 1, pp. 142–145.
2. Kamada, H., Tsutsumi, Y., Yamamoto, Y., Kihira, T., Kaneda, Y., Mu, Y., Tsunoda, S., Nakagawa, S., and Mayumi, T., Cancer Res., 2000, vol. 60, no. 22, pp. 6416–6420.
3. Li, Y.P., Pei, Y.Y., Zhang, X.Y., Gu, Z.H., Zhou, Z.H., Yuan, W.F., Zhou, J.J., Zhu, J.H., and Gao, X.J., J. Control. Release, 2001, vol. 71, no. 2, pp. 203–211.
4. Shmelev, V.A., Interferon-gamma, faktor nekroza opukholei, timozin-al’fa1 – protivoinfektsionnye i protivoopukholevye tsitokiny i preparaty (Interferon-gamma, Tumor Necrosis Factor, Thymosin-alpha1—Anti-Infection and Antitumor Cytokines and Drugs), Moscow: Medpraktika, 2008.
5. Caraglia, M., Marra, M., Naviglio, S., Botti, G., Addeo, R., and Abbruzzese, A., Expert Opin. Pharmacother., 2010, vol. 11, no. 1, pp. 141–154.